a public good project by the
Synthesis
Company
of California

© 2026

Giovanni Porta | doi.page

0 works0 citations0 h-index

Giovanni Porta

Publications by Year

Research Areas

Immunodeficiency and Autoimmune Disorders, Blood disorders and treatments, Chronic Lymphocytic Leukemia Research, Chronic Myeloid Leukemia Treatments, Thyroid Cancer Diagnosis and Treatment

Most-Cited Works

→ Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene(1998)757 cited
→ A new oncogene in human thyroid papillary carcinomas and their lymph-nodal metastases(1987)413 cited
→ Ret oncogene activation in human thyroid neoplasms is restricted to the papillary cancer subtype.(1992)392 cited
→ Gene p53 mutations are restricted to poorly differentiated and undifferentiated carcinomas of the thyroid gland.(1993)373 cited
Deletions of 17p and p53 mutations in preneoplastic lesions of the lung.(1992)
→ Molecular Characterization of a Thyroid Tumor-Specific Transforming Sequence Formed by the Fusion of ret Tyrosine Kinase and the Regulatory Subunit RIα of Cyclic AMP-Dependent Protein Kinase A(1993)237 cited
TRK-T1 is a novel oncogene formed by the fusion of TPR and TRK genes in human papillary thyroid carcinomas.(1992)

Frequent activation of ret protooncogene by fusion with a new activating gene in papillary thyroid carcinomas.

(1994)

→ Molecular characterization of a thyroid tumor-specific transforming sequence formed by the fusion of ret tyrosine kinase and the regulatory subunit RI alpha of cyclic AMP-dependent protein kinase A.(1993)169 cited

→ Metabolic effects of TiO2 nanoparticles, a common component of sunscreens and cosmetics, on human keratinocytes(2013)168 cited